Clinical Trials Browser

Phase 2 × Interleukin-11 × Other hematologic neoplasm × Clear all

NCT00493181 2012-02-20

Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients

Phase 2 Completed

8 enrolled 3 charts

Classical hematologyMyeloidOther hematologic neoplasm

Leukemia, Thrombocytopenia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive